Faculdade de Medicina da Bahia >
Artigos Publicados em Periódicos (Medicina) >

Please use this identifier to cite or link to this item: http://repositorio.ufba.br/ri/handle/ri/15681

Title: IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
Other Titles: Liver International
Authors: Cavalcante, Lourianne N.
Abe Sandes, Kiyoko
Angelo, Ana Luiza Dias
Machado, Taisa Manuela Bonfim
Lemaire, Denise Carneiro
Mendes, Carlos Maurício Cardeal
Pinho, João Renato Rebello
Malta, Fernanda
Lyra, Luiz Guilherme Costa
Lyra, André Castro
Keywords: Antiviral therapy;Genetic ancestry;Hepatitis C;IL28B;Polymorphism;Single nucleotide
Issue Date: 2012
Abstract: Background IL28B polymorphisms are predictors of therapy response in hepatitis C virus (HCV) patients. We do not know whether they are markers of treatment response in admixed populations or not. Aims To determine whether IL28B polymorphisms are predictors of therapy response in patients with HCV from an admixed population and are influenced by genetic ancestry. Methods rs12979860 and rs8099917 were genotyped in 222 HCV patients treated with pegylated interferon and ribavirin. Ancestry was determined using genetic markers. Results IL28B rs12979860 C/C was associated with sustained virological response (SVR), whereas C/T and T/T were associated with failure to therapy (P = 1.12 × 10−5). IL28B rs8099917 T/T was associated with SVR, and G/G and G/T were associated with nonresponse/relapse (NR/R) (P = 8.00 × 10−3). Among HCV genotype 1 patients with C/C genotype, genomic ancestry did not interfere with therapy response. Among patients with rs12979860 T/T genotype, African genetic contribution was greater in the NR/R group (P = 1.51 × 10−3), whereas Amerindian and European genetic ancestry contribution were higher in the SVR group (P = 3.77 × 10−3 and P = 2.16 × 10−2 respectively). Among HCV type 1 patients with rs8099917 T/T, African genetic contribution was significantly greater in the NR/R group (P = 5.0 × 10−3); Amerindian and European ancestry genetic contribution were greater in the SVR group. Conclusion IL28B rs12979860 and rs8099917 polymorphisms were predictors of therapy response in HCV genotypes 1, 2 and 3 subjects from an admixed population. Genomic ancestry did not interfere with response to therapy in patients with rs12979860 C/C, whereas it interfered in patients with C/T and T/T genotypes. Among HCV genotype 1 rs8099917 T/T patients, genomic ancestry interfered with response to therapy.
Description: Texto completo: acesso restrito. p. 476–486
URI: http://repositorio.ufba.br/ri/handle/ri/15681
ISSN: 1478-3223
Appears in Collections:Artigos Publicados em Periódicos (Medicina)

Files in This Item:

File Description SizeFormat
Lourianne N. Cavalcante.pdf225.43 kBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


    Universidade Federal da Bahia

Contate-nos. Saiba mais sobre o RI/UFBA